Clinical Trials · NCT01181986
The Study of Exenatide Action on Vessel Function in Type 2 Diabetes and Prediabetes
- Phase
- Phase 4
- Recruitment status
- Completed
- Sponsor
- Carl T. Hayden VA Medical Center
- Enrollment
- 76
- Start date
- Aug 2010
- Locations
- 1 site, United States
- Primary endpoint
- Reactive Hyperemia Index (RHI)